Pharmafile Logo
Pharmafocus logo
Advanced Search
Xarelto picture

NICE recommends Xarelto for stroke prevention

May 23, 2012
Sales and Marketing Bayer, DVT, NICE, Pradaxa, Xarelto, anticoagulant

NICE is recommending Bayer’s anticoagulant pill Xarelto to help reduce the risk of stroke in certain patients.  The watchdog’s final …

News
Hack day image

NHS to host first ‘hack day’ event

May 22, 2012
Medical Communications, Sales and Marketing Goldacre, Gray, London, NHS, hack event

The NHS will host its first ‘hack day’ event this weekend in London, with the aim of sharing software that …

News
Lansley iPad image

Government sets out new information strategy for NHS

May 22, 2012
Medical Communications, Sales and Marketing GPs, Lansley, NHS, digital, government, reforms

The Department of Health has outlined its plan for greater use of information technology in the NHS in a bid …

News

Pharma manufacturing news in brief

May 22, 2012
Manufacturing and Production Codexis, IPEC, Novozymes Biopharma, SGS International, Vetter

Excipients trade body IPEC will set up a branch in India next month, plus updates for Codexis, SGS International, Vetter …

News
oliver_leatham

MSI appoints new market access consultant

May 22, 2012
Business Services, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, appointment, market access

Strategic marketing firm The MSI Consultancy has appointed Oliver Leatham as market access consultant. Oliver has a wide experience as …

Appointment
Lonza image

Gene therapy specialist and Lonza forge production pact

May 22, 2012
Manufacturing and Production Avalanche, Lonza, Phil Taylor

Avalanche Biotechnologies, a US company developing gene therapies for ocular diseases, has signed a manufacturing collaboration with Lonza of Switzerland.  …

News

Pharma R&D model no help to developing countries

May 22, 2012
Research and Development, Sales and Marketing HIV, MSF, Médecins Sans Frontières, R&D

Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …

News
Pfizer picture

Pfizer cutting 40% of Premarin plant workforce

May 22, 2012
Manufacturing and Production

Pfizer has said it plans to cut 40% of jobs at a manufacturing facility in Manitoba, Canada, that supplies the …

News

Sir Gordon Duff to host this year’s Clinical Discovery Annual Conference

May 22, 2012
Medical Communications, Sales and Marketing

Events 4 Healthcare is delighted that Sir Gordon Duff will be chairing this year’s Clinical Discovery Annual Conference on 16 …

News

Mitsubishi Tanabe exits API business

May 22, 2012
Manufacturing and Production API, Mitsubishi, Phil Taylor, Tanabe

Mitsubishi Tanabe Pharma has said it will withdraw from the fine chemical business, including active pharmaceutical ingredient (API) supply, and …

News

Biotec strengthens team with new appointments

May 22, 2012
Manufacturing and Production

Bridgend, Wales: Biotec Services International has announced the appointment of two senior industry professionals as the company embarks on an …

Appointment

UCB signs new epilepsy research pact with Imperial

May 21, 2012
Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy

UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …

News

ICON makes two senior appointments

May 21, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRO, ICON, appointment

ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research. …

Appointment

Ovarian cancer charity wins GSK/King’s Fund award

May 21, 2012
Medical Communications, Sales and Marketing GSK, awards, charity, king's fund, ovarian cancer

A charity which aims to increase the chances of survival for patients with a poorly-treated form of cancer is to …

News

World’s first stem cell drug approved in Canada

May 21, 2012
Sales and Marketing Canada, regenerative medicine, stem cell

Canada has approved the world’s first stem cell drug, marking an historic day for the burgeoning therapy.  Osiris’ Prochymal is …

News

GSK buys more of Theravance

May 18, 2012
Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance

GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …

News

OPEN Health invests in Harvey Walsh

May 18, 2012
Medical Communications Harvey Walsh, Open Health

Harvey Walsh, a market access and healthcare intelligence company, is to join forces with OPEN Health, the healthcare communications group.  OPEN Health …

News
screen_shot_2012-05-18_at_09

Teva re-elects Chairman of the Board

May 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frost, Teva

Teva has announced that its Board of Directors has unanimously voted to re-elect Dr Phillip Frost as Chairman of the …

Appointment

Plavix loses US patent protection

May 18, 2012
Sales and Marketing BMS, FDA, Lipitor, Pfizer, Plavix, Sanofi

Sanofi and Bristol-Myers Squibb’s blood thinner Plavix has lost its patent protection in the US.  The drug, which made $6.6 …

News
Andrew Lansley

NICE to be sidelined on cost effectiveness – once again

May 17, 2012
Sales and Marketing NICE, VBP

Health secretary Andrew Lansley has confirmed that NICE will no longer direct the NHS on the cost effectiveness of drugs. …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026